Brief: Biotec Renews Clinical Trial Deal With Memorial Sloan Kettering Cancer Center
Nov 14 (Reuters) - Biotec Pharmacon ASA BIOTEC.OL :
* BIOTEC RENEWS CLINICAL TRIAL AGREEMENT WITH MEMORIAL SLOAN KETTERING CANCER CENTER
* ADDITIONAL 60 PATIENTS ARE EXPECTED TO BE RECRUITED TO THE STUDY PROTOCOL BY END OF 2019
Source text for Eikon: ID:nWkr1Z1HwS
Further company coverage: BIOTEC.OL
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))